- Previous close
0.1700 - Open
0.1620 - Bid 0.1620 x --
- Ask 0.1700 x --
- Day's range
0.1620 - 0.1620 - 52-week range
0.1180 - 0.4700 - Volume
100 - Avg. Volume
440,777 - Market cap (intra-day)
41.522M - Beta (5Y monthly) 0.66
- PE ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings date 15 Aug 2024
- Forward dividend & yield --
- Ex-dividend date 6 May 2022
- 1y target est
--
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It offers cord blood, cord lining, and cord tissue banking services, including processing and storage of stem cells; and various diagnostics services, such as newborn genetic screening, pediatric vision and ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, and newborn metabolic screening. The company also provides Moms Up, a mobile app for pregnancy and parenting resources for moms and moms-to-be. In addition, it provides medical laboratory, marketing, and property investment services. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.
www.cordlife.com--
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Diagnostics & Research
Industry
Recent news: P8A.SI
View more
Performance overview: P8A.SI
Trailing total returns as of 15/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: P8A.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: P8A.SI
View moreValuation measures
Market cap
43.57M
Enterprise value
-13.05M
Trailing P/E
10.73
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
1.19
Price/book (mrq)
0.36
Enterprise value/revenue
--
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
-30.21%
Return on assets (ttm)
-4.62%
Return on equity (ttm)
-8.51%
Revenue (ttm)
36.61M
Net income avi to common (ttm)
-11.06M
Diluted EPS (ttm)
-0.0400
Balance sheet and cash flow
Total cash (mrq)
59.54M
Total debt/equity (mrq)
2.37%
Levered free cash flow (ttm)
662.5k